ArticleThoracic cancer2022

A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy.

Kai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.